Article
No evidence for a causal contribution of bioavailable testosterone to ADHD in sex-combined and sex-specific two-sample Mendelian randomization studies.
European child & adolescent psychiatry - 1 Oct 2024
Dinkelbach Lars, Peters Triinu, Grasemann Corinna, Hebebrand Johannes, Hinney Anke, Hirtz Raphael
Abstract excerpt
The higher prevalence of attention-deficit/hyperactivity disorder (ADHD) in males raises the question of whether testosterone is implicated in ADHD risk. However, cross-sectional studies did not identify an association between ADHD and testosterone levels. Mendelian randomization (MR) studies can overcome limitations inherent to association studies, especially of reverse causation and residual confounding. In the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
